New Cross Hospital, Royal Wolverhampton Hospitals NHS Trust, Wednesfield Way, Wolverhampton, WV10 0QP, UK.
Clinical Trials Research Centre (CTRC), North West Hub for Trials Methodology/University of Liverpool, Liverpool, L12 2AP, UK.
Breast. 2017 Oct;35:182-190. doi: 10.1016/j.breast.2017.07.016. Epub 2017 Jul 30.
The introduction of biological and synthetic meshes has revolutionised the practice of implant-based breast reconstruction (IBBR) but evidence for effectiveness is lacking. The iBRA (implant Breast Reconstruction evAluation) study is a national trainee-led project that aims to explore the practice and outcomes of IBBR to inform the design of a future trial. We report the results of the iBRA National Practice Questionnaire (NPQ) which aimed to comprehensively describe the provision and practice of IBBR across the UK.
A questionnaire investigating local practice and service provision of IBBR developed by the iBRA Steering Group was completed by trainee and consultant leads at breast and plastic surgical units across the UK. Summary data for each survey item were calculated and variation between centres and overall provision of care examined.
81 units within 79 NHS-hospitals completed the questionnaire. Units offered a range of reconstructive techniques, with IBBR accounting for 70% (IQR:50-80%) of participating units' immediate procedures. Units on average were staffed by 2.5 breast surgeons (IQR:2.0-3.0) and 2.0 plastic surgeons (IQR:1.0-3.0) performing 35 IBBR cases per year (IQR:20-50). Variation was demonstrated in the provision of novel different techniques for IBBR especially the use of biological (n = 62) and synthetic (n = 25) meshes and in patient selection for these procedures.
The iBRA-NPQ has demonstrated marked variation in the provision and practice of IBBR in the UK. The prospective audit phase of the iBRA study will determine the safety and effectiveness of different approaches to IBBR and allow evidence-based best practice to be explored.
生物和合成网片的引入彻底改变了基于植入物的乳房重建(IBBR)的实践,但缺乏有效性的证据。iBRA(植入乳房重建评估)研究是一个由培训师主导的全国性项目,旨在探索 IBBR 的实践和结果,为未来的试验设计提供信息。我们报告了 iBRA 国家实践问卷(NPQ)的结果,该问卷旨在全面描述英国各地 IBBR 的提供和实践情况。
由 iBRA 指导小组开发的一项调查 IBBR 当地实践和服务提供情况的问卷,由英国各地的乳房和整形手术单位的培训师和顾问负责人填写。对每个调查项目的汇总数据进行了计算,并检查了中心之间的差异和整体护理的提供情况。
在 79 家 NHS 医院的 81 个单位完成了问卷。各单位提供了一系列的重建技术,其中 IBBR 占参与单位即时手术的 70%(IQR:50-80%)。各单位平均配备 2.5 名乳房外科医生(IQR:2.0-3.0)和 2.0 名整形外科医生(IQR:1.0-3.0),每年进行 35 例 IBBR 手术(IQR:20-50)。在 IBBR 的新的不同技术的提供方面存在差异,特别是生物(n=62)和合成(n=25)网片的使用以及这些手术的患者选择方面存在差异。
iBRA-NPQ 表明,英国 IBBR 的提供和实践存在明显差异。iBRA 研究的前瞻性审核阶段将确定不同 IBBR 方法的安全性和有效性,并允许探索基于证据的最佳实践。